课题基金 / 基金详情

SYSTEMIC TOLERANCE AND SAFETY OF THE TRANSDERMAL THERAPEUTIC SYSTEM

SYSTEMIC TOLERANCE AND SAFETY OF THE TRANSDERMAL THERAPEUTIC SYSTEM
透皮治疗系统的全身耐受性和安全性
批准号：
3850479
负责人：
RONALD S SWERDLOFF
金额：
$0.0万
依托单位：
LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/3850479
关键词：
blood chemistry clinical trials dihydrotestosterone estradiol follicle stimulating hormone human subject human therapy evaluation hypogonadism injection /infusion luteinizing hormone testosterone topical drug application

项目摘要

项目成果

RONALD S SWERDLOFF的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To compare the efficacy and safety of a transdermal therapeutic system for testosterone to those of testosterone injection in a group of hypogonadal men. Physical exams, blood counts, chemistries and sex hormones (testosterone, dihydrotestosterone, LH, FSH and estradiol) will be performed bimonthly.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PHASE II CLINICAL STUDIES WITH LHRH AGONISTS
TOLERANCE AND SAFETY OF TRANSDERMAL TESTERONE
OLIGOSPERMIA--CONTROLLED COMPARISON OF TWO ANTI-ESTROGENS
OLIGOSPERMIA--CONTROLLED COMPARISON OF TWO ANTI-ESTROGENS
海外基金